Skip to main content

Animations

MJFF Publications

6371 - 6380 of 6456 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2025
  • 2025
  • 2021
  • 2012
  • 2020
  • 2026
  • 2018
  • 2017
  • Summary Details
    OPEN
    Title: Are Clinical Certainty Ratings Helpful in the Diagnosis of Parkinson's Disease?
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12589
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2
    Journal Name: Neurochemical Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11064-018-2650-4
    Citation Count: 18
  • Summary Details
    OPEN
    Title: A Novel α‐Synuclein K58N Missense Variant in a Patient with Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.70030
    Citation Count: 2
  • Summary Details
    OPEN
    Title: A prospective controlled study of a wearable rhythmic vibrotactile device for tremor in Parkinson’s disease
    Journal Name: Clinical Neurophysiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.clinph.2025.02.255
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based study
    Journal Name: The Lancet Regional Health - Americas
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.lana.2021.100136
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Competitive HIF Prolyl Hydroxylase Inhibitors Show Protection against Oxidative Stress by a Mechanism Partially Dependent on Glycolysis
    Journal Name: ISRN Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2013/598587
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Using Wearable Sensors and Machine Learning to Automatically Detect Freezing of Gait during a FOG-Provoking Test
    Journal Name: Sensors
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/s20164474
    Citation Count: 67
  • Summary Details
    OPEN
    Title: APOE ‐stratified Proteomic and Metabolomic Analysis Reveals Mitochondrial Dysfunction Inflammation and Lipid Dysregulation in Alzheimer's Disease
    Journal Name: Advanced Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/advs.202513872
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The GBA p.Trp378Gly mutation is a probable French‐Canadian founder mutation causing Gaucher disease and synucleinopathies
    Journal Name: Clinical Genetics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/cge.13405
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists
    Journal Name: British Journal of Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/bph.14123
    Citation Count: 22
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.